ced pexels 8139068

High-potency marijuana is sending more youth to the ER – Times Union

✦ New
CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely.
⚒ Cannabis News  |  CED Clinic
Youth SafetyEmergency MedicineHigh-Potency ThcCannabis HyperemesisAdolescent Health
Why This Matters

Emergency department presentations among youth using high-THC cannabis products represent a critical clinical safety signal that requires immediate attention from pediatricians, emergency physicians, and addiction specialists. These cases often involve cannabis hyperemesis syndrome, acute psychosis, or severe intoxication requiring medical intervention.

Clinical Summary

High-potency cannabis products, typically containing THC concentrations above 15-20%, are associated with increased emergency department visits among adolescents and young adults. The primary presentations include cannabis hyperemesis syndrome (cyclical vomiting), acute anxiety or panic reactions, and cannabis-induced psychotic episodes. Youth are particularly vulnerable due to ongoing brain development and limited experience gauging appropriate dosing with concentrated products like dabs, vapes, and edibles.

Dr. Caplan’s Take

“I’m seeing more young patients in crisis from products that didn’t exist when I started practicing cannabis medicine. The gap between product potency and user education has become a public health emergency requiring immediate clinical and policy attention.”

Clinical Perspective
🧠 Clinicians should screen for specific product types and potencies, not just ‘marijuana use,’ when evaluating youth patients. Parents and teens need education about the dramatic difference between traditional flower and today’s concentrated products. Emergency providers should be prepared for longer observation periods and supportive care protocols for high-THC intoxication.

💬 Join the Conversation

Have a question about how this applies to your situation? Ask Dr. Caplan →

Want to discuss this topic with other patients and caregivers? Join the forum discussion →

FAQ

What is cannabis hyperemesis syndrome?

Cannabis hyperemesis syndrome (CHS) is a condition characterized by cyclic episodes of severe nausea and vomiting in chronic cannabis users. It typically occurs in people who have used cannabis regularly for years and is often associated with high-potency THC products.

Why are high-potency THC products a particular concern?

High-potency THC products contain significantly higher concentrations of psychoactive compounds than traditional cannabis. These products increase the risk of adverse effects including cannabis hyperemesis syndrome, particularly in frequent users.

How does cannabis use affect youth safety?

Cannabis use in youth can impact brain development, academic performance, and increase risk of mental health issues. Emergency department visits related to cannabis use have been rising among young people, particularly with high-potency products.

What should emergency medicine providers know about cannabis-related visits?

Emergency providers should be aware of increasing cannabis-related presentations, including hyperemesis syndrome and acute intoxication from high-potency products. Recognition of these conditions is crucial for appropriate treatment and patient education.

What clinical considerations are important for cannabis hyperemesis syndrome?

Treatment typically involves supportive care with antiemetics and IV fluids, though hot showers may provide temporary relief. The most effective long-term treatment is complete cessation of cannabis use, which should be discussed with patients.